A shortened method for the assay with Centocor radioimmunoassay kit

We have conducted a series of basic studies about Centocor's CA125 RIA Kit, especially for the conditions of the incubation. The standard curve and the outcome of recovery test gained through the standard method and the shortened method are quite decent. As for the incubation time, it took longer than 20 hours and 6-18 hours inthe standard method and shortened one respectively. As our conclusion, these results suggest that the shortened method can be adopted as a practical one as well as the standard method, provided that careful attention is paid to several peripheral conditions in the assay.     

Clinical evaluation of immunoglobulin-E radioimmunoassay kit

An IgE RIA kit (Sandwich method; Dainabott), is used to obtain the following results. (1) Standard curve: Since the range of reproduction rate show 3.16-7.07% (C.V.), the curve become steep. (2) Incubations under controlled situation: Both of the incubations are controlled at 15-30 degrees C for 2 h. (3) Reproducibility test: Coefficients of variation (C.V.) of intra-assay and inter-assay variation are 2.32-3.94% and 2.92-3.92% respectively. (4) Recovery test: A result of the recovery test range between 100.1-101.7%. (5) Dilution test: Multiple dilution effects are observed. (6) Average counts of the serum IgE for the controlled and diseased groups: The average counts of the serum IgE for the controlled group, atopic diseased group, allergic rhinitis group and allergic bronchial asthma are 144.9 +/- 183.2 IU/ml, 1,099.0 +/- 2,782.4 IU/ml, 1,150.9 +/- 2,063.3 IU/ml and 600.7 +/- 686.4 IU/ml respectively. The value of the diseased groups have tendency to show higher averages than the controlled group. Since the controlled and diseased groups show wide distributions of the serum IgE level, there is no significant difference of two variations. However the diseased groups have tendency to show higher ratio of the serum IgE level in blood than the controlled groups. These basic researches are quite meaningful, because they are able to apply for a supplemental diagnosis of the atopic and parasitic disease.     

Clinical usefulness of a trypsin radioimmunoassay kit

From the clinical use of RIA-gnost trypsin kit, the following results were obtained. 1. Standard curve showed a steep and good curve was shown. 2. Incubation: The condition for the first incubation was set at the room temperature for 10-24 hours and that for the second incubation at the room temperature for 3-5 hours. With these settings, satisfactory results were obtained. 3. Reproducibility and recovery: The C.V. of the reproducibility and the recovery were considered superior, and the values were below 10% and +/- 3%, respectively. 4. Correlation between trypsin and serum elestase-1: An excellent positive correlation (coefficient of correlation r = 0.889) was shown. 5. Serum trypsin concentration of normal and pancreatic diseases: The normal range was from 100 to 500 ng/ml. Acute pancreatitis rose obviously. Diabetes mellitus and chronic pancreatitis was below 500 ng/ml and the pancreatic cancer showed a tendency to scatter in the range of 50-1,250 ng/ml. The above results indicated that serum trypsin can be easily measured with high precision by using this method. Thus the method is considered useful for the diagnosis of pancreatic diseases.     

A fundamental and clinical study of ferritin 'Eiken' radioimmunoassay kit

We have measured serum ferritin level using double antibody radioimmunoassay kit (Eiken ICL) and evaluated the characteristics of the kit and clinical usefulness. Satisfactory results were observed in standard curve, reproducibility, dilution and recovery test. In clinical evaluation, we have measured in normal subjects and patients with various diseases. The range in normal males and females were 13.0-158.7 ng/ml and 7.3-73.0 ng/ml, respectively. Serum ferritin level was elevated in patients with hepatoma, biliary cancer, lung cancer and other malignant diseases. Measurement of serum ferritin value would be useful in the monitoring of cancer patients.     

A new method for the production of a magnetic immunosorbent used in radioimmunoassay and immunoradiometric assay

A method has been developed enabling the direct coupling of first or second antibody to finely dispersed magnetite (Fe₃O₄). The immunosorbent thus produced was applied in various radioimmunoassay systems (T3, T4, TSH, Cortisol) for the separation of bound and free antigens. The elimination of the need for precoating the magnetic particles with a polymer has several advantages. One of them lies in the ease of one-step production of the immunosorbent and other is the high antibody/magnetite ratio. The influence of the concentration of the immunosorbent and detergent (TWEEN 20 or TRITON X-100) on the assay parameters (Bo, NSB, etc.) has been systematically investigated and the optimum concentration of the magnetizable particles and detergent has been determined. The reliability of magnetic separation has been validated by comparing it with the conventional PEG separation method.This work was performed in the scope of the Coordinated Research ProgrammeAntibodies Immobilized on Magnetic Particles for Radioimmunoassay and Immunoradiometric Assay (No6 487CF) organized and supported by the International Atomic Energy Agency, Vienna. The authors express their thanks to the Agency for supporting this work.     

A rapid magnetizable solid phase radioimmunoassay kit for human placental lactogen

The radioimmunoessay of human placental lactogen (HPL) with separation of antibody bound and free hormone was achieved by the magnetizable solid phase coupled to antibody. The precision, accuracy, sensitivity and specificity of the method has been carefully checked in this study and the procedure of the assay was performed at room temperature. The above parameters were evaluated by recovery test (99%); within assays (4%), between assays (5%), sensitivity (0.04 g/ml) and there was no obvious cross reactivity with human growth hormone (hGH) and human chorionic gonadotropin (hCG).